Ancora.ai Cancer Clinical Trials Finder(@Ancora_AI) 's Twitter Profileg
Ancora.ai Cancer Clinical Trials Finder

@Ancora_AI

Our mission is to help all cancer patients find & access clinical trials.

Check out our award-winning tool and register for updates on https://t.co/MWQuNTxurQ.

ID:1197835492303220736

linkhttps://www.ancora.ai/ calendar_today22-11-2019 11:13:44

4,8K Tweets

1,3K Followers

5,0K Following

Dr Liz O'Riordan(@Liz_ORiordan) 's Twitter Profile Photo

Out now on 'So Now I've Got Breast Cancer' - Everything you need to know about Radiotherapy with Jo and Naman from Rad Chat
Listen now apple.co/4aLsUf4

Plus there's the weekly poem from Donna Ashworth

BreastCancer Chat WW #BCCWW LobularBCUK Breast Cancer Now

Out now on 'So Now I've Got Breast Cancer' - Everything you need to know about Radiotherapy with Jo and Naman from @rad__chat Listen now apple.co/4aLsUf4 Plus there's the weekly poem from @Donna_ashworth @bccww @LobularBCUK @BreastCancerNow
account_circle
Erika Hamilton, MD(@ErikaHamilton9) 's Twitter Profile Photo

A great reminder that this year's early drugs are the standard drugs in 5-10 years.

The progress in oncology is too fast to dismiss the role of clinical trials!!!!

account_circle
Lydia Makaroff(@lydiamakaroff) 's Twitter Profile Photo

The World Bladder Cancer Patient Coalition survey showed that 84-90% of bladder cancer patients are not being asked if they would like to participate in a research study. We need to ensure that all clinical trials involve patient organisations in the design of the study, to ensure that it is relevant…

account_circle
#TumorBoardTuesday(@TumorBoardTues) 's Twitter Profile Photo

1/7 Treatment of has changed significantly in 2023/2024! Join us 👇for our case wrap up: Guru P. Sonpavde, MD & Jon Anker, MD, PhD review key concepts-
-- Choosing 1L tx in mUC
-- Role of FGFR inhibitor (erda)
-- New approaches coming soon!

1/7 Treatment of #urothelialcarcinoma #BladderCancer has changed significantly in 2023/2024! Join us 👇for our case wrap up: @sonpavde & @JonAnker1 review key concepts- -- Choosing 1L tx in mUC -- Role of FGFR inhibitor (erda) -- New approaches coming soon! #TumorBoardTuesday
account_circle
LobularBCUK(@LobularBCUK) 's Twitter Profile Photo

Join our first free Virtual Meetup 7pm Wednesday 15 May in partnership with @FutureDreams & connect other women diagnosed with this distinct disease. buff.ly/3U5SGVT

Join our first free Virtual #Lobular Meetup 7pm Wednesday 15 May in partnership with @FutureDreams & connect other women diagnosed with this distinct disease. buff.ly/3U5SGVT
account_circle
NET Cancer Day(@netcancerday) 's Twitter Profile Photo

NET patients can be experts in research advocacy and get involved in from design to implementation.
☑️Watch these informative and insightful presentations by prominent NET investigators: incalliance.org/researcher-ins…

NET patients can be experts in research advocacy and get involved in #clinicaltrials from design to implementation. ☑️Watch these informative and insightful presentations by prominent NET investigators: incalliance.org/researcher-ins… #LetsTalkAboutNETs
account_circle
Neuroendocrine Cancer UK #NotJustNECancer(@ncukcharity) 's Twitter Profile Photo

PERT update. With thanks to authors Mary Phillips, Laura McGeeney, Jacqueline Lowdon & Kerry-Lee Watson for their expertise. Endorsed by BSG (Panc) The Pancreatic Society of Great Britain & Ireland Pancreatic Cancer UK Guts UK Charity Cystic Fibrosis Trust CF Medical Assoc & British Dietetic Assoc bit.ly/43MZcUP

account_circle
Hillary (Stires) Andrews, PhD(@HillStirSci) 's Twitter Profile Photo

🚨 Early career metastasis cancer researchers! 🚨

Interested in working with advocates? Want to attend Metastasis Research Society Biennial Congress in June?

Apply for , hosted by Theresa's Research Foundation and Metastasis Research Society with funding from The Breast Cancer Research Foundation by April 15. theresasresearch.org/marp/2024/3/14…

account_circle
#TumorBoardTuesday(@TumorBoardTues) 's Twitter Profile Photo


💥The power🦾duo of Florez and Patel are BACK🎉to discuss the treatment of🫁Lung Cancer👍

📢Join us Tuesday, 04-09-2024 at 8PM ET as Narjust Florez, MD, FASCO & Shruti Patel, MD 🗣️Peri-operative Immunotherapy for

RT and bring others into the discussion‼️

#TumorBoardTuesday 💥The power🦾duo of Florez and Patel are BACK🎉to discuss the treatment of🫁Lung Cancer👍 📢Join us Tuesday, 04-09-2024 at 8PM ET as @NarjustFlorezMD & @ShrutiPatelMD 🗣️Peri-operative Immunotherapy for #lungcancer RT and bring others into the discussion‼️
account_circle
Pashtoon Kasi MD, MS(@pashtoonkasi) 's Twitter Profile Photo

AACR
👇🏾See this piece on published Cancer Today.

🩸Liquid biopsies are here to stay.

Going beyond prognostication to being integral/predictive biomarkers.

OncoAlert

📌cancertodaymag.org/fall-2023/the-…

#AACR24 @AACR 👇🏾See this piece on #ctDNA #LiquidBiopsies published @CancerTodayMag. 🩸Liquid biopsies are here to stay. Going beyond prognostication to being integral/predictive biomarkers. @OncoAlert 📌cancertodaymag.org/fall-2023/the-…
account_circle
Neuroendocrine Cancer UK #NotJustNECancer(@ncukcharity) 's Twitter Profile Photo

Delighted to be in Canada speaking at the CNETS conference. We may be miles apart geographically but issues for the cancer community are the same across globe. Much determination here to get this cancer the recognition it deserves. Thank you for inviting us

Delighted to be in Canada speaking at the @CNETSCanada conference. We may be miles apart geographically but issues for the #neuroendocrine cancer community are the same across globe. Much determination here to get this cancer the recognition it deserves. Thank you for inviting us
account_circle
Paolo Tarantino(@PTarantinoMD) 's Twitter Profile Photo

Recurrence data from the phase 2 trial published on The Lancet. A de-escalated, PET-response-based neoadjuvant treatment strategy for stage I-IIIA HER2+ breast cancer led to 94.8% 3-year iDFS rate and halved the incidence of severe AEs.
thelancet.com/journals/lance…

Recurrence data from the #PHERGain phase 2 trial published on @TheLancet. A de-escalated, PET-response-based neoadjuvant treatment strategy for stage I-IIIA HER2+ breast cancer led to 94.8% 3-year iDFS rate and halved the incidence of severe AEs. #bcsm thelancet.com/journals/lance…
account_circle
Jessica Thomas, MSW, LCSW(@jsalinisthomas) 's Twitter Profile Photo

Living with NETs in the New England area? We have an excellent agenda for our in-person NET Impact Thrivership & Research patient and caregiver education conference on 5/4 in Providence, RI. Register: shorturl.at/FQ159 Pamela Kunz, MD, FASCO Christopher Heaphy ElyseG NET Research Foundation

Living with NETs in the New England area? We have an excellent agenda for our in-person NET Impact Thrivership & Research patient and caregiver education conference on 5/4 in Providence, RI. Register: shorturl.at/FQ159 @PamelaKunzMD @Chris_Heaphy @ElyseGellerman @CureNETs
account_circle
#TumorBoardTuesday(@TumorBoardTues) 's Twitter Profile Photo


🏹We are taking aim at true targeted therapy this week🎯💊

📢Join us Tuesday, 04.02.2024 at 8PM ET as Guru P. Sonpavde, MD & Jon Anker, MD, PhD🗣️tailoring Tx in metastatic with FGFR🎯💊

RT and bring others into the discussion‼️

#TumorBoardTuesday 🏹We are taking aim at true targeted therapy this week🎯💊 📢Join us Tuesday, 04.02.2024 at 8PM ET as @sonpavde & @JonAnker1🗣️tailoring Tx in metastatic #urothelialcancer with FGFR🎯💊 RT and bring others into the discussion‼️
account_circle
Jo Taylor(@abcdiagnosis) 's Twitter Profile Photo

Secondaries On The 2nd
We want you to know about the signs and symptoms of so sharing our infographics that highlight what you should be aware of if you’ve had a primary diagnosis



buff.ly/3TUSuJ2

Secondaries On The 2nd We want you to know about the signs and symptoms of #MetastaticBreastCancer so sharing our infographics that highlight what you should be aware of if you’ve had a primary #breastcancer diagnosis #2ndsonthe2nd #secondarybreastcancer buff.ly/3TUSuJ2
account_circle
Pashtoon Kasi MD, MS(@pashtoonkasi) 's Twitter Profile Photo

Was a delight to be on the The Late Night Oncology Show 🎙️🎙️🇧🇷 in the company of some wonderful physicians & scientists discussing 🧬🩸.

👇🏾Episode available on Spotify.

💡More now than ever it is important to understand the limitations & best use case/scenarios.

open.spotify.com/episode/7F0NPG…

Was a delight to be on the @LateNightOnc🎙️🇧🇷 in the company of some wonderful physicians & scientists discussing #ctDNA🧬🩸. 👇🏾Episode available on Spotify. 💡More now than ever it is important to understand the limitations & best use case/scenarios. open.spotify.com/episode/7F0NPG…
account_circle